RxDoctor Payments Data

Douglas Klassett, MD

Family Medicine · Richmond, VANPI 1174557516

Payments from drug & device makers

$15,798in general payments, 2019–2025

Across 1,047 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • Pfizer$1K
  • AstraZeneca$1K
  • Amgen$1K
  • Boehringer Ingelheim$864
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$15,773100%
  • Education$250%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk130$1,780
AbbVie(2 entities)115$1,467
Pfizer95$1,401
AstraZeneca46$1,337
Amgen87$1,095
Boehringer Ingelheim71$864
GSK69$834
Lilly USA, LLC54$766
Abbott31$653
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC36$544
Takeda Pharmaceuticals U.S.A., Inc.45$452
Amarin Pharma, Inc.21$387
Teva Pharmaceuticals USA, Inc.19$292
Johnson & Johnson26$286
Gilead14$256
Esperion Therapeutics, Inc.13$162
Astellas Pharma US Inc11$160
Merck10$157
Otsuka America Pharmaceutical, Inc.7$154
Phathom Pharmaceuticals, Inc.3$153
Supernus Pharmaceuticals, Inc.9$138
Novartis8$127
Biohaven Pharmaceuticals, Inc.6$122
Irhythm Technologies, Inc.2$110
Dexcom, Inc.5$97
Xeris Pharmaceuticals, Inc.4$87
Kowa Pharmaceuticals America, Inc.6$86
Idorsia Pharmaceuticals US Inc2$85
Ironwood Pharmaceuticals, Inc5$83
Shield Therapeutics Inc2$83
Regeneron Healthcare Solutions, Inc.4$76
Sanofi-aventis U.S. LLC5$76
Dynavax Technologies Corporation3$73
Ardelyx, Inc.5$71
Viiv Healthcare Company4$67
Antares Pharma, Inc.4$63
Lundbeck LLC3$60
Nalpropion Pharmaceuticals LLC4$59
Biohaven Pharmaceutical Holding Company Ltd.3$58
Corium, LLC2$52
Exact Sciences3$49
Shire North American Group Inc4$46
Currax Pharmaceuticals LLC3$44
Bayer3$42
Medtronic2$41
Eisai Inc.2$38
Endo Pharmaceuticals Inc.2$31
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$31
Watermark Medical, Inc.2$30
Edwards Lifesciences2$30
Amneal Pharmaceuticals LLC2$27
Mylan Specialty L.p.1$25
Pacira Pharmaceuticals Incorporated1$25
ARS Pharmaceuticals Operations, Inc.1$23
Atricure, Inc.1$22
Ultragenyx Pharmaceutical Inc.1$22
Viatris Specialty LLC1$22
Vertex1$21
Daiichi Sankyo Inc.1$20
Seqirus USA Inc1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,798 in reported general payments places this provider in the 95th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$228,221
Medicare patients
386
Services billed
6,405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin48$48,445
EliquisApixaban45$40,678
XareltoRivaroxaban53$40,024
MounjaroTirzepatide38$36,707
FarxigaDapagliflozin Propanediol56$34,194
OzempicSemaglutide31$28,859
JanuviaSitagliptin Phosphate32$13,442
Tresiba Flextouch U-200Insulin Degludec23$9,915
LinzessLinaclotide15$9,180
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$8,251
Emgality PenGalcanezumab-Gnlm12$8,159
Repatha SureclickEvolocumab12$6,631
Aripiprazole18$6,235
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,984
Adderall XrDextroamphetamine/Amphetamine12$4,835

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$864$48,44548 claims
PfizerEliquis$1,401$40,67845 claims
Johnson & JohnsonXarelto$286$40,02453 claims
Lilly USA, LLCMounjaro$766$36,70738 claims
AstraZenecaFarxiga$1,337$34,19456 claims
Novo NordiskOzempic$1,780$28,85931 claims
MerckJanuvia$157$13,44232 claims
AbbVieLinzess$1,467$9,18015 claims
GSKAnoro Ellipta$834$4,98411 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$27$2,979305 claims
Sanofi-aventis U.S. LLCLantus$76$1,83018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →